ARCHIVES

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

This article is from The Cancer Letter archive.

Vol. 38 No. 18 | May 4, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Howard Skipper Retires; Oglesby To Head SRI; John Montgomery Named Kettering-Meyer Director

December 19, 1980

NCI Planning Phase III Study Of Avastin For Metastatic Colorectal Cancer

June 27, 2003

Breast Cancer Funding: Shalala Approves Agreement Over Disputed $14 Million

August 8, 1997

Executive Committee, Board of Scientific Advisors concur.

January 2, 2004

California Land Control Grant, Need Administrator

April 21, 1978

In Congress: House Subcommittee Postpones FY2000 Markup; Porter Seeks 8% increase for NIH

July 23, 1999